Altieri F D, Watson J T, Taylor K D
National Heart, Lung and Blood Institute, Division of Heart and Vascular Diseases, Bethesda, MD 20892.
J Biomater Appl. 1986 Jul;1(1):106-56. doi: 10.1177/088532828600100104.
The National Heart, Lung, and Blood Institute (NHLBI) has sponsored considerable research directed toward basic studies on the etiology of heart disease and atherosclerosis. While progress has been very encouraging there are still significant numbers of patients with end-stage heart disease. NHLBI initiated goal-oriented research activities on the artificial heart based upon the recommendation of the National Heart Advisory Council in 1964. The major goal of the Artificial Heart Program was to develop devices which could be effectively used to rehabilitate patients with end-stage heart disease. This paper will describe the evolution and specific program goals of the Artificial Heart Program and provide a description of the left ventricular assist system (LVAS) and total artificial heart (TAH) research efforts. Specific attention will be directed toward defining device requirements, descriptions of the blood pump and energy converter, control system operation and energy transmission methods. A summary of experimental results and current development status will also be provided.
美国国立心肺血液研究所(NHLBI)资助了大量针对心脏病和动脉粥样硬化病因基础研究的项目。尽管进展十分令人鼓舞,但仍有相当数量的患者患有终末期心脏病。基于国家心脏咨询委员会1964年的建议,NHLBI启动了关于人工心脏的目标导向型研究活动。人工心脏项目的主要目标是开发能够有效用于使终末期心脏病患者康复的设备。本文将描述人工心脏项目的发展历程和具体项目目标,并介绍左心室辅助系统(LVAS)和全人工心脏(TAH)的研究工作。将特别关注确定设备要求、血泵和能量转换器的描述、控制系统操作以及能量传输方法。还将提供实验结果和当前发展状况的总结。